0.89 USD
↗ 0.01 (1.47%)AT CLOSE (11:59 AM EDT)
Invivyd, Inc. Common Stock
IVVDNASDAQ • USD
0.90
↗ 0.01 (1.27%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
0.90
↗ 0.01 (1.27%)
Market: CLOSED
IVVD is currently priced at $0.89. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest IVVD is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 26, 2026.
Open?$0.86
High?$0.92
Low?$0.86
Prev. Close?$0.88
Volume?27.6M
Avg. Volume?6.0M
VWAP?$0.88
Rel. Volume?4.61x
Bid / Ask
Bid?$0.74 × 100
Ask?$1.03 × 100
Spread?$0.29
Midpoint?$0.88
Valuation & Ratios
Market Cap?262.2M
Shares Out?294.6M
Float?155.5M
Float %?66.7%
P/E Ratio?N/A
P/B Ratio?1.29
EPS?-$0.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Employees
122
Market Cap
258.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-08-06
Address
209 CHURCH STREET
NEW HAVEN, CT 06510
Phone: (781) 819-0080
NEW HAVEN, CT 06510
Phone: (781) 819-0080
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?97
Short Sent.?46
Piotroski F-Score?2/9Weak
Altman Z-Score?-1.73Distress
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?22.14%Squeeze Risk
Short Interest?34.4M
Days to Cover?6.0
Free Float155.5M
Avg Daily Volume5.7M
Settlement Date2026-06-15
Financial Health
Current Ratio?6.47Strong
Quick Ratio?6.47Strong
Cash Ratio?5.82Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?1.29CHEAP▾
Peers100
S&P91
P/S?4.69FAIR▾
Peers100
S&P32
P/FCF?N/A▾
EV/EBITDA?-1.0CHEAP▾
S&P97
EV/Sales?1.40CHEAP▾
Peers100
S&P85
Returns & Efficiency
ROE?-38.2%WEAK▾
S&P3
ROA?-32.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-79455000
Enterprise Value?$78.0M
Fundamentals ratios updated end of day